or Try an Advanced Search...

    Technical Analysis for VRAX - Virax Biolabs Group Limited

    Grade Last Price % Change Price Change
    D 1.10 -5.17% -0.06
    VRAX closed down 5.17 percent on Monday, July 1, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical VRAX trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup -5.17%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.17%
    NR7 Range Contraction -5.17%
    Narrow Range Bar Range Contraction -5.17%
    Inside Day Range Contraction -5.17%
    Older End-of-Day Signals for VRAX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Up 2% about 9 hours ago
    Non-ADX 1,2,3,4 Pullback Entry about 10 hours ago
    1,2,3, Pullback Entry about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VRAX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Virax Biolabs Group Limited is an innovative biotechnology group focused on the detection and diagnosis of viral diseases, with a particular interest in the field of immunology. Virax Biolabs Group Limited is currently developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Medicine Immunology Hepatitis B Hepatitis Virus Malaria Viral Disease Herpes Herpes Simplex Monkeypox

    Is VRAX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 10 Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
    Jun 7 Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
    Jun 6 Virax surges amid bird flu concerns
    Jun 6 Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Apr 25 EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes
    Apr 25 Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
    Apr 16 Virax Biolabs to Participate at ESCMID Global 2024
    Mar 15 Virax Biolabs receives Nasdaq notification letter regarding minimum bid price deficiency
    Mar 15 Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
    See more VRAX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.3
    52 Week Low 0.6
    Average Volume 1,791,119
    200-Day Moving Average 1.54
    50-Day Moving Average 1.06
    20-Day Moving Average 1.49
    10-Day Moving Average 1.40
    Average True Range 0.22
    RSI (14) 41.18
    ADX 35.75
    +DI 24.73
    -DI 20.63
    Chandelier Exit (Long, 3 ATRs) 2.15
    Chandelier Exit (Short, 3 ATRs) 1.49
    Upper Bollinger Bands 2.14
    Lower Bollinger Band 0.84
    Percent B (%b) 0.2
    BandWidth 86.76
    MACD Line 0.03
    MACD Signal Line 0.12
    MACD Histogram -0.0925
    Fundamentals Value
    Market Cap 2.6 Million
    Num Shares 2.36 Million
    EPS -17.70
    Price-to-Earnings (P/E) Ratio -0.06
    Price-to-Sales 25.14
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.23
    Resistance 3 (R3) 1.25 1.22 1.21
    Resistance 2 (R2) 1.22 1.19 1.21 1.20
    Resistance 1 (R1) 1.16 1.16 1.14 1.14 1.20
    Pivot Point 1.13 1.13 1.12 1.12 1.13
    Support 1 (S1) 1.07 1.10 1.06 1.06 1.00
    Support 2 (S2) 1.04 1.07 1.03 1.00
    Support 3 (S3) 0.98 1.04 0.99
    Support 4 (S4) 0.97